During the past decade, Centre Intégré de Recherches Biocliniques d'Abidjan conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Intégré de Recherches Biocliniques d'Abidjan" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centre Intégré de Recherches Biocliniques d'Abidjan" are "HIV Infections" (2 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "Centre Intégré de Recherches Biocliniques d'Abidjan" in a lesser frequency.

Most popular intervention types in "Centre Intégré de Recherches Biocliniques d'Abidjan" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral medications" (1 trials), "Antiretroviral medications+Isoniazid prophylaxis" (1 trials), "Efavirenz (EFV)" (1 trials), "Indinavir (IDV)" (1 trials) and "Lamivudine (3TC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Intégré de Recherches Biocliniques d'Abidjan" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre Intégré de Recherches Biocliniques d'Abidjan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Intégré de Recherches Biocliniques d'Abidjan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Intégré de Recherches Biocliniques d'Abidjan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".